| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Interest income: |
| Interest income on loans | 113.0 | 105.0 | 100.5 | 95.5 | 81.6 | 70.2 | 62.8 | 56.9 |
| | 129.7 | 115.0 | 111.6 | 109.0 | 95.8 | 84.3 | 76.8 | 70.6 |
| Interest expense: |
| Interest on borrowings | 0.6 | 0.8 | 1.1 | 4.0 | 3.8 | 2.1 | 1.3 | 1.1 |
| | 0.6 | 2.2 | 2.6 | 6.1 | 5.8 | 7.0 | 5.4 | 4.8 |
| Net interest income | 118.3 | 110.4 | 99.2 | 88.0 | 84.0 | 77.7 | 71.6 | 65.9 |
| Provision for loan losses | | | | | | 2.7 | 2.0 | 1.3 |
| Net interest income after provision for loan losses | 118.3 | 110.4 | 99.2 | 88.0 | 84.0 | 74.9 | 69.5 | 64.6 |
| Deposit and loan fees | | | | | | | | 9.2 |
| Gain on sale of investments, net | | | | | | | | 0.1 |
| Other non-interest income | 30.9 | 32.4 | 32.7 | 28.6 | 28.9 | 27.6 | 27.8 | 18.8 |
| Total non-interest income | 30.9 | 32.4 | 32.7 | 28.6 | 28.9 | 27.6 | 27.8 | 28.1 |
| Non-interest expenses | 81.5 | 78.0 | 70.7 | 67.5 | 65.1 | 62.7 | 59.6 | 57.4 |
| Pre-tax income before non-recurring items | 62.9 | 17.8 | 18.4 | 15.7 | 47.8 | 42.0 | 39.9 | 37.5 |
| Non-recurring items | | 2.7 | 2.5 | 2.5 | 2.5 | 2.2 | 2.1 | 2.2 |
| Pre-tax income | 62.9 | 15.1 | 15.9 | 13.3 | 45.3 | 39.9 | 37.7 | 35.3 |
| Income taxes | 14.1 | 0.3 | 0.4 | 0.5 | 0.7 | 10.5 | 11.2 | 10.6 |
| Tax rate | 22.4% | 2.1% | 2.7% | 3.5% | 1.5% | 26.4% | 29.7% | 30.1% |
| Net income | 48.8 | 64.4 | 51.9 | 47.1 | 36.3 | 29.3 | 26.5 | 24.7 |
| Net margin | 32.7% | 43.1% | 37.4% | 38.0% | 30.0% | 28.6% | 27.3% | 26.6% |
| |
| Basic EPS | $2.95 | $4.02 | $3.26 | $2.97 | $2.37 | $1.99 | $1.87 | $1.80 |
| Diluted EPS | $2.95 | $4.01 | $3.25 | $2.96 | $2.36 | $1.98 | $1.86 | $1.80 |
| |
| Shares outstanding (basic) | 16.5 | 16.0 | 15.9 | 15.8 | 15.3 | 14.7 | 14.2 | 13.7 |
| Shares outstanding (diluted) | 16.5 | 16.1 | 15.9 | 15.9 | 15.4 | 14.8 | 14.3 | 13.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |